{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T21:04:10Z","timestamp":1784667850826,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003581","name":"National Intelligence Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartandlung.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart &amp; Lung"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.hrtlng.2025.102701","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:08:00Z","timestamp":1767859680000},"page":"102701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cardiovascular disease-associated admissions in patients with Cystic Fibrosis: A 7-Year U.S. National Inpatient Sample Analysis"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7479-8495","authenticated-orcid":false,"given":"Adnan","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3834-144X","authenticated-orcid":false,"given":"Anchit","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maulinkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Shahabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Elzeneini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waseem","family":"Nabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzamil","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouman","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar A.","family":"Trillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge E.","family":"Lascano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.hrtlng.2025.102701_bib0001","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/gut.52.8.1159","article-title":"Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas","volume":"52","author":"Ahmed","year":"2003","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.hrtlng.2025.102701_bib0002","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.hrtlng.2025.102701_bib0003","first-page":"54","article-title":"Cystic fibrosis liver disease in the new era of cystic fibrosis transmembrane conductance regulator (CFTR) modulators","volume":"50","author":"Eldredge","year":"2024","journal-title":"Paediatr Respir Rev"},{"issue":"Suppl 2","key":"10.1016\/j.hrtlng.2025.102701_bib0004","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jcf.2019.08.015","article-title":"Energy balance and obesity in individuals with cystic fibrosis","volume":"18","author":"Litvin","year":"2019","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"issue":"10","key":"10.1016\/j.hrtlng.2025.102701_bib0005","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thorax-2023-220558","article-title":"Long-term impact of ivacaftor on mortality rate and health outcomes in people with cystic fibrosis","volume":"79","author":"Merlo","year":"2024","journal-title":"Thorax"},{"issue":"21","key":"10.1016\/j.hrtlng.2025.102701_bib0006","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/jama.2023.8120","article-title":"Cystic Fibrosis: a Review","volume":"329","author":"Ong","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.hrtlng.2025.102701_bib0007","unstructured":"Understanding Changes in Life Expectancy, Cystic Fibrosis Foundation. Accessed September 13, 2025. https:\/\/www.cff.org\/managing-cf\/understanding-changes-life-expectancy."},{"issue":"6","key":"10.1016\/j.hrtlng.2025.102701_bib0008","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3390\/life13061305","article-title":"Future Comorbidities in an Aging Cystic Fibrosis Population","volume":"13","author":"Ticona","year":"2023","journal-title":"Life"},{"issue":"6","key":"10.1016\/j.hrtlng.2025.102701_bib0009","doi-asserted-by":"crossref","first-page":"C1555","DOI":"10.1152\/ajpcell.1998.275.6.C1555","article-title":"Characterization of CFTR expression and chloride channel activity in human endothelia","volume":"275","author":"Tousson","year":"1998","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.hrtlng.2025.102701_bib0010","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0008-6363(95)00245-6","article-title":"CFTR chloride channels in human and simian heart","volume":"31","author":"Warth","year":"1996","journal-title":"Cardiovasc Res"},{"issue":"12","key":"10.1016\/j.hrtlng.2025.102701_bib0011","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1016\/j.bbadis.2017.08.011","article-title":"Mechanisms of endothelial cell dysfunction in cystic fibrosis","volume":"1863","author":"Totani","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"10.1016\/j.hrtlng.2025.102701_bib0012","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00174-2023","article-title":"Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: a multinational retrospective cohort study","volume":"62","author":"Frost","year":"2023","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.hrtlng.2025.102701_bib0013","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jcf.2024.09.012","article-title":"Cardiac Structure and Function in People with Cystic Fibrosis","volume":"23","author":"Duus","year":"2024","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"issue":"1","key":"10.1016\/j.hrtlng.2025.102701_bib0014","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s13023-021-01965-4","article-title":"Health Disparities among adults cared for at an urban cystic fibrosis program","volume":"16","author":"DiMango","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"10.1016\/j.hrtlng.2025.102701_bib0015","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1089\/jwh.2014.4985","article-title":"Gender differences in outcomes of patients with cystic fibrosis","volume":"23","author":"Harness-Brumley","year":"2014","journal-title":"J Womens Health 2002"},{"key":"10.1016\/j.hrtlng.2025.102701_bib0016","unstructured":"HCUP-US NIS Overview. Accessed March 8, 2025. https:\/\/hcup-us.ahrq.gov\/nisoverview.jsp."},{"issue":"5","key":"10.1016\/j.hrtlng.2025.102701_bib0017","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/AOG.0000000000004959","article-title":"Trends in and Outcomes of Deliveries Complicated by Cystic Fibrosis","volume":"140","author":"Schmidt","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.hrtlng.2025.102701_bib0018","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3390\/ijerph19020795","article-title":"National Hospitalization Trends and the Role of Preventable Hospitalizations among Centenarians in the United States (2000-2009)","volume":"19","author":"Twersky","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"10.1016\/j.hrtlng.2025.102701_bib0019","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jaci.2012.08.009","article-title":"Modeling asthma exacerbations through lung function in children","volume":"130","author":"Wu","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.hrtlng.2025.102701_bib0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12874-022-01685-8","article-title":"A comparison of statistical methods for modeling count data with an application to hospital length of stay","volume":"22","author":"Fernandez","year":"2022","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"10.1016\/j.hrtlng.2025.102701_bib0021","article-title":"Standards for the care of people with cystic fibrosis (CF); Planning for a longer life","volume":"23","author":"A","year":"2024","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"key":"10.1016\/j.hrtlng.2025.102701_bib0022","volume":"156","year":"2021"},{"key":"10.1016\/j.hrtlng.2025.102701_bib0023","unstructured":"FDA Approves New Breakthrough Therapy For Cystic Fibrosis, FDA. Accessed March 23, 2025. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-breakthrough-therapy-cystic-fibrosis."},{"issue":"1","key":"10.1016\/j.hrtlng.2025.102701_bib0024","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jcf.2021.04.016","article-title":"Cardiovascular complications in cystic fibrosis: a review of the literature","volume":"21","author":"Poore","year":"2022","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"issue":"4","key":"10.1016\/j.hrtlng.2025.102701_bib0025","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jcf.2025.02.001","article-title":"Cardiovascular function in people with cystic fibrosis on Elexacaftor\/Tezacaftor\/Ivacaftor: a cross-sectional, observational, single-centre study","volume":"24","author":"Clayton","year":"2025","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"key":"10.1016\/j.hrtlng.2025.102701_bib0026","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S1569-1993(24)00149-8","article-title":"WS07.04 Impact of CFTR modulator therapy on cardiovascular risk in cystic fibrosis: a longitudinal cohort analysis","volume":"23","author":"England","year":"2024","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1016\/j.hrtlng.2025.102701_bib0027","unstructured":"Sibayan J., Barnes-Lomen V. Studying the Presence of CFRD Complications with Thoughtful Recruitment of Multiethnic Minoritized (SPeCTRuM) Groups (SPeCTRuM). ClinicalTrials.gov identifier: NCT06837181."},{"issue":"1","key":"10.1016\/j.hrtlng.2025.102701_bib0028","doi-asserted-by":"crossref","DOI":"10.1136\/bmjhci-2024-101381","article-title":"Assessing the validity of ICD-10 administrative data in coding comorbidities","volume":"32","author":"Pan","year":"2025","journal-title":"BMJ Health Care Inform"},{"key":"10.1016\/j.hrtlng.2025.102701_bib0029","unstructured":"Fibrosis Foundation C. PATIENT REGISTRY ANNUAL DATA REPORT. 2021 Annual Data Report."},{"issue":"3","key":"10.1016\/j.hrtlng.2025.102701_bib0030","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"}],"container-title":["Heart &amp; Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956325002924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956325002924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:41:53Z","timestamp":1784666513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956325002924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"alternative-id":["S0147956325002924"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2025.102701","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular disease-associated admissions in patients with Cystic Fibrosis: A 7-Year U.S. National Inpatient Sample Analysis","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2025.102701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102701"}}